1 Prediabetes Comorbidities and Complications. 2 Common Comorbidities of Prediabetes Obesity CVD Dyslipidemia Hypertension Renal failure Cancer Sleep.

Slides:



Advertisements
Similar presentations
1 Prediabetes Screening and Monitoring. 2 Prediabetes Epidemiologic evidence suggests that the complications of T2DM begin early in the progression from.
Advertisements

Lysaght, J Am Soc Nephrol, 2002 Number of patients worldwide treated with chronic dialysis from 1990 to ,000 1,490,000 2,500,000.
Chronic kidney disease: [insert title here] Insert name, title, date here Insert acknowledgements here.
Aggressive Hyperglycemia Management. Significant hospital hyperglycemia requires close follow-up Previously diagnosed diabetes and elevated A1C Without.
Task Force on Diabetes and CVD (ESC and EASD) European Heart Journal 2007;28:
Chapter 1: CKD in the General Population 2014 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
Glucose Tolerance Test Diabetes Mellitus Dr. David Gee FCSN Nutrition Assessment Laboratory.
Diabetes in Pregnancy Screening.
Benefits of intensive multiple risk factor intervention.
Welch Center Uniting Medicine & Public Health Prevalence of Albuminuria, and its Relationship to Decreased GFR and Outcomes Josef Coresh, MD, PhD Director,
Lesley Stevens MD Tufts-New England Medical Center
Canadian Diabetes Association 2013 Clinical Practice Guidelines Targets for Glycemic Control Chapter 8 S. Ali Imran, Rémi Rabasa-Lhoret, Stuart Ross.
Diabetic Microvascular Disease: The Role of Glycemic Control and the Impact on Public Health Robert E. Ratner, MD MedStar Research Institute Georgetown.
DIABETES AND EYE DISEASE: LEARNING OBJECTIVES
The Diagnosis of Diabetes Mellitus
1 Prediabetes Comorbidities and Complications. 2 Common Comorbidities of Prediabetes Obesity CVD Dyslipidemia Hypertension Renal failure Cancer Sleep.
Diabetes – A 21 st Century Epidemic Diagnosis and what is it A common disease An expensive disease A serious disease A treatable disease A preventable.
Screening for Diabetes in Pregnancy 1. Gestational Diabetes Mellitus Screening GDM, gestational diabetes mellitus. Handelsman YH, et al. Endocr Pract.
Management of Chronic Kidney Disease Stages 1 – 3 Prepared for: Agency for Healthcare Research and Quality (AHRQ)
1 Prediabetes Burden. 2 Epidemiology: Health Performance Gaps Prevalence Risk factors –Metabolic syndrome –Obesity Clinical risks of prediabetes –Progression.
Early Detection and Prevention of Renal Failure Linda Fried, MD, MPH.
Prediabetes Screening and Monitoring 1. Rationale for Prediabetes Screening Epidemiologic evidence suggests the complications of diabetes begin early.
ACCORD - Action to Control Cardiovascular Risk in Diabetes ADVANCE - Action in Diabetes to Prevent Vascular Disease VADT - Veterans Administration Diabetes.
Therapy of Type 2 Diabetes Mellitus: UPDATE
Criteria for Diagnosis of DM * Testing must be repeated on separate day. FPG is the preferred test ** Symptoms of DM IFG = Impaired fasting glucose IGT.
6 / 5 / RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 3 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR) ALLHAT.
Diabetes Mellitus Ibrahim Sales, Pharm.D. Assistant Professor of Clinical Pharmacy King Saud University
Epidemiology of Diabetes Mellitus by Santi Martini Departemen of Epidemiology Faculty of Public Health University of Airlangga.
Standards of Medical Care for Patients with Diabetes Mellitus John Guzek, MD March 2003.
Reducing the Risk of T2DM: What Works?
Shadi Al-Ahmadi. The Presentation will include: Hypertension Dyslipidemia CVD Type 2 Diabetes-Associated Retinopathy Diabetic Periphral Neuropathy Diabetic.
1 Prediabetes Comorbidities and Complications. 2 Common Comorbidities of Prediabetes Obesity CVD Dyslipidemia Hypertension Renal failure Cancer Sleep.
Leveraging Weight Loss in the Treatment of Type 2 Diabetes Part 1 of 4.
Chronic elevation of blood glucose levels leads to the endothelium cells taking in more glucose than normal damaging the blood vessels. 2 types of damage.
Risk of Type 2 Diabetes and It’s Complications Along The Continuum of Fasting Plasma Glucose Gregory A. Nichols, PhD Collaborative Diabetes Education Conference.
Consider testing if person is: – Overweight or obese with additional risk factor for diabetes – Age 45 or older Obtain: A1C or FPG or 2-hour plasma glucose.
Diabetes and the Eye Karen B. Saland, M.D. August 18, 2008.
Diabetes mellitus “ Basic approach” Dr Sajith.V.S MBBS,MD (Gen Med )
A Diabetes Outcome Progression Trial
Diabetes Mellitus 101 for Cardiologists (and Alike): 2015
Chapter 1: CKD in the General Population 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
Background There are 12 different types of medications to lower blood sugar levels in patients with type 2 diabetes. It is widely agreed upon that metformin.
Diabetes Prevention Program (DPP)
Impact of Diabetes on Cardiovascular Risk C.Richard Conti M.D. MACC Oct 16,2004 GWICC Beijing, PRC.
ALLHAT 6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (3 GROUPS by GFR)
6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (4 GROUPS by GFR) ALLHAT.
Part 3. Diabetes Report Card: HbA 1c Levels in the United States Hoerger TJ, et al. Diabetes Care. 2008;31: Patients (%) HbA 1c (%)
1 به نام خدا. Epidemiology of chronic kidney disease 2.
Diabetes and the Kidney Richard Kingston Department of Renal Medicine Kent and Canterbury Hospital.
Circulation. 2014;129: Association Between Plasma Triglycerides and High-Density Lipoprotein Cholesterol and Microvascular Kidney Disease and Retinopathy.
Measures of Hyperglycemia Random plasma glucose (RPG)—without regard to time of last meal Fasting plasma glucose (FPG)—before breakfast Oral glucose tolerance.
1 Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled.
Clinical Outcomes with Newer Antihyperglycemic Agents
Figure 1.1 Prevalence of CKD by stage among NHANES participants,
Diabetes Fact Sheet in Korea 2016.
Clinical Outcomes with Newer Antihyperglycemic Agents
Section 4: Managing progression of CKD
ACCORD Microvascular Outcomes
Pathophysiology and Prevention of Heart Disease in Diabetes Mellitus
Screening for Diabetes in Pregnancy
Chapter 1: CKD in the General Population
Screening and Monitoring
Screening and Monitoring
So What is Albuminuria? An elevated urinary albumin excretion is a marker of endothelial dysfunction that symbolizes the kidney’s way to translate the.
Diabetes Fact Sheet in Korea 2016.
The percentage of subjects with de novo development of renal function impairment (GFR
Screening for Diabetes in Pregnancy
Chapter 1: CKD in the General Population
American Journal of Kidney Diseases
Diabetes – A 21st Century Epidemic
Presentation transcript:

1 Prediabetes Comorbidities and Complications

2 Common Comorbidities of Prediabetes Obesity CVD Dyslipidemia Hypertension Renal failure Cancer Sleep disorders Handelsman Y, et al. Endocr Pract. 2011;17(suppl 2):1-53.

3 Clinical Risks of Not Treating Prediabetes Are Substantial Microvascular disease –Retinopathy –Neuropathy –Nephropathy Cardiovascular disease (CVD) –Heart disease –Stroke –Peripheral vascular disease Zhang Y, et al. Population Health Management. 2009;12: Garber AJ, et al. Endocr Pract. 2008;14:

4 Prevalence of CKD in US Adults With Undiagnosed T2DM or Prediabetes: *Plus a single measurement of albuminuria. CKD, chronic kidney disease; FPG, fasting plasma glucose; GFR, glomerular filtration rate; MDRD, modification of diet in renal disease; NHANES = National Health and Nutrition Examination Survey; T2DM, type 2 diabetes mellitus. Plantinga LC, et al. Clin J Am Soc Nephrol. 2010;5: Population prevalence of stages 1-4 CKD, with estimation of GFR by the MDRD Study equation, by diabetes status. Undiagnosed diabetes is defined as FPG ≥126 mg/dL, without a report of provider diagnosis; prediabetes is defined as FPG ≥100 and <126 mg/dL; and no diabetes is defined as FPG <100 mg/dL. NHANES Population (%)

5 Impaired Fasting Glucose and Correlations With Diabetes, Hypertension, and Retinopathy Hypertension (HTN) defined according to WHO criteria, HTN cutoff >140/90 mm Hg Population-based cross-sectional studies % of Patients Blue Mountains Eye Study (BMES) (N=3654, 99% white) FPG=95.4 mg/dL Australian Diabetes, Obesity and Lifestyle Study (AusDiab) (N=2773; ~95% white) FPG=117 mg/dL Multi-ethnic Study of Atherosclerosis (MESA) (N=6237; 40% white, 27% black, 22% Hispanic, 12% Chinese) FPG=106 mg/dL Wong TY, et al. Lancet. 2008;371:

6 FPG, fasting plasma glucose. Wong TY, et al. Lancet. 2008;371: FPG Thresholds Above Which the Prevalence of Retinopathy Increases Blue Mountains Eye Study Australian Diabetes, Obesity, and Lifestyle Study Multi-ethnic Study of Atherosclerosis On visual inspection mmol/l ( mg/dL) mmol/l ( mg/dL) No clear threshold Change point model 5.2 mmol/l (94 mg/dL) 6.3 mmol/l (113 mg/dL) No clear threshold

7 FPG, fasting plasma glucose. Wong TY, et al. Lancet.2008;371: Relationship Between FPG and 5-Year Incident Retinopathy

8 Association of Retinopathy and Albuminuria With Glycemia The prevalence of retinopathy rises dramatically with increasing deciles of glycemia; for microalbuminuria, the increase in prevalence was more gradual FPG values corresponded well with WHO diagnostic cut points for diabetes while the 2- hour PG value did not A1C thresholds were similar for both retinopathy and microalbuminuria FPG, fasting plasma glucose; PG, plasma glucose; WHO, World Health Organization. Tapp RJ, et al. Diabetes Res Clin Pract. 2006;73:

9 Diabetic Retinopathy in the DPP *Mild/moderate NPDR: -microaneurysms plus ≥1 of the following: venous loops >0/1; soft exudates, intraretinal microvascular abnormalities or venous beading; retinal hemorrhages; hard exudates >0/1; or soft exudates >0/1. † P=0.035 vs nondiabetic. DPP, Diabetes Prevention Program; ETDRS, Early Treatment of Diabetic Retinopathy Study; IRMA, intratetinal microvascular abnormalities; NPDR, nonproliferative diabetic retinopathy. DPP Research Group. Diabet Med ;24: Nondiabetic retinopathy ETDRS levels Diabetic retinopathy ETDRS levels † 7.9

10 Diabetic Nephropathy in the DPP ACR, albumin to creatinine ratio; DPP, Diabetes Prevention Program. DPP. Diabetes Care. 2009;32: End of study prevalence of elevated ACR (≥30 mg/g) by T2DM status and treatment group

11 Diabetic Nephropathy in the DPP End of study status Placebo (N=940) Metformin (N=931) Intensive Lifestyle Intervention (N=931) Stable status883 (93.9%)861 (92.5%)863 (92.7%) Worsened albuminuria33 (3.5%)35 (3.8%)28 (3.0%) Improved albuminuria24 (2.6%)35 (3.8%)40 (4.3%) Net increase in elevated ACR 9 (1.0%)0 (0.0%)-12 (-1.3%) ACR, albumin to creatinine ratio; DPP, Diabetes Prevention Program. DPP. Diabetes Care, 2009;32:

12 DREAM Trial: Impact on Nephropathy EventRosiglitazonePlaceboHR (95% CI) Normal → microalbuminuria 241 (9.2%)285 (10.8%)0.83 ( ) Microalbuminuria → proteinuria 6 (0.23%)13 (0.49%)0.46 ( ) ↓ eGFR ≥ 30%82 (3.1%)105 (4.0%)0.77 ( ) Microalbuminuria → normal 193 (52.5%)185 (48.7%)1.18 ( ) Cl, confidence interval; DREAM, Diabetes Reduction Assessment with Ramipril and Rosiglitazone Medication; eGFR, estimated glomerular filtration rate; HR, hazard ratio. DREAM Investigators. Diabetes Care. 2008;31:

13 Elevated Risk of CVD Prior to Clinical Diagnosis of Type 2 Diabetes Nondiabetic throughout the study Prior to diagnosis of diabetes After diagnosis of diabetes Diabetic at baseline Relative Risk CVD, cardiovascular disease. Hu FB, et al. Diabetes Care. 2002;25: Female nurses with no CVD at baseline aged years and followed from 1976 to 1996 (N=117,629)